TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34085495

Group type: EXPERIMENTAL
Intervention: Individualized homeopathic medicines (IH)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study: 36366201

Group type: EXPERIMENTAL
Intervention: VR‐3D stimulation
Number of subjects: 16

Group type: COMPARATOR
Intervention: 2D stimulation
Number of subjects: 16
Study: 35285115

Group type: EXPERIMENTAL
Intervention: Group-based pain and stress self-management intervention (PASS)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Individual physiotherapy (IPT)
Number of subjects: 156
Study: 33530845

Group type: EXPERIMENTAL
Intervention: Laparoscopic 3D HD system (system B)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Laparoscopic 4K UHD 2D system (system A)
Number of subjects: 62
Study: 35857769

Group type: EXPERIMENTAL
Intervention: Positive parenting programme (two 2‐hour interactive talks, total 4 hours)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Positive parenting programme
Number of subjects: 144

Group type: COMPARATOR
Intervention: Control group (n = 69)
Number of subjects: 144
Study: 36196685

Group type: EXPERIMENTAL
Intervention: Algorithm-based difficult airway trolley (DAT)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Standard difficult airway trolley (DAT)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Algorithm-based DAT
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Higher percentage of female team members
Number of subjects: 16
Study: 34432394

Group type: COMPARATOR
Intervention: Manual method (n = 52)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Reciprocating automated preparation system (WaveOne®) (n = 53)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Rotary preparation system (ProTaper Next®) (n = 52)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: All methods
Number of subjects: 157
Study: 32605284

Group type: EXPERIMENTAL
Intervention: Beetroot Juice (BJ)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 12
Study: 36197121

Group type: EXPERIMENTAL
Intervention: Intubation and sphincterotomy with wire-guided incision knife plus balloon dilatation (ISBD)
Number of subjects: 270

Group type: COMPARATOR
Intervention: Endoscopic sphincterotomy (EST)
Number of subjects: 270

Group type: COMPARATOR
Intervention: Endoscopic sphincterotomy plus balloon dilation
Number of subjects: 270
Study: 34086880

Group type: EXPERIMENTAL
Intervention: AB023 (0.25 or 0.5 mg/kg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 32594479

Group type: EXPERIMENTAL
Intervention: Individualized life skills training (2 sessions per week for 8 weeks, total 16 sessions)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Single-session awareness training (control group)
Number of subjects: 32
Study: 32553558

Group type: EXPERIMENTAL
Intervention: alfapump® system implantation and concomitant hernia repair (CT group)
Number of subjects: 38

Group type: COMPARATOR
Intervention: intermittent paracentesis hernia repair (ST group)
Number of subjects: 38
Study: 32674231

Group type: EXPERIMENTAL
Intervention: B vitamins supplementation (folic acid and VB-6)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo tablet
Number of subjects: 0
Study: 34667261

Group type: EXPERIMENTAL
Intervention: AZD8529 (80 mg daily for 3 days)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 32819017

Group type: EXPERIMENTAL
Intervention: SBAR report to physician tool
Number of subjects: 165
Study: 36174602

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (LMWH) doses adapted according to anti-Xa peak levels
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: ClotPro analyses (viscoelastic hemostatic whole blood test)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Higher enoxaparin doses
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Monitoring of anti-Xa levels
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: ClotPro's RVV test
Number of subjects: 91
Study: 33866248

Group type: EXPERIMENTAL
Intervention: CFI-400945 (PLK4 inhibitor) combined with radiation therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control or single-agent treatment
Number of subjects: 0
Study: 32700952

Group type: EXPERIMENTAL
Intervention: Psychological First Aid (PFA)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Usual Services (US)
Number of subjects: 172
Study: 34937590

Group type: EXPERIMENTAL
Intervention: Minocycline (200 mg/day)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Minocycline
Number of subjects: 71
Study: 33242870

Group type: EXPERIMENTAL
Intervention: Guggulu and Triphala
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 36444987

Group type: EXPERIMENTAL
Intervention: Adenotonsillectomy (AT)
Number of subjects: 464

Group type: COMPARATOR
Intervention: Watchful waiting with supportive care (WWSC)
Number of subjects: 464
Study: 34992511

Group type: EXPERIMENTAL
Intervention: Whole-Body Vibration (WBV)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 32
Study: 32739460

Group type: EXPERIMENTAL
Intervention: Moderate-intensity aerobic training (50-60 min/day, 3 days/week at 65-70% of maximal heart rate reserve) for 12 weeks
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (no intervention, maintained normal lifestyle)
Number of subjects: 29
Study: 32542627

Group type: EXPERIMENTAL
Intervention: Cholecalciferol supplementation
Number of subjects: 553

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 553
Study: 34582258

Group type: EXPERIMENTAL
Intervention: Keenoa™ diet tracking application
Number of subjects: 102

Group type: COMPARATOR
Intervention: Conventional pen and paper method
Number of subjects: 102
Study: 33256546

Group type: EXPERIMENTAL
Intervention: Audiovisual modality
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Narrative style
Number of subjects: 262
Study: 34396709

Group type: EXPERIMENTAL
Intervention: Tailored website intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Untailored website intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 32701865

Group type: EXPERIMENTAL
Intervention: Test group with access to the knot-tying station plus the knot testing station
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group with access to only the knot-tying station
Number of subjects: 60
Study: 32055864

Group type: EXPERIMENTAL
Intervention: 2 consecutive night shifts
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: 4 consecutive night shifts
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: 7 consecutive night shifts
Number of subjects: 73

Group type: COMPARATOR
Intervention: Recovery days (2+2, 4+4, 7+7)
Number of subjects: 73
Study: 32672635

Group type: EXPERIMENTAL
Intervention: Intra-Tenon injection of 0.1 ml of 0.01% MMC (TI group)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Subconjunctival application of MMC-soaked sponges (TS group)
Number of subjects: 82
Study: 35451013

Group type: EXPERIMENTAL
Intervention: 1, 2, 4, 8 or 12 µg CG beta added to follitropin delta
Number of subjects: 620

Group type: COMPARATOR
Intervention: Follitropin delta only
Number of subjects: 620

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 620
Study: 33106225

Group type: EXPERIMENTAL
Intervention: Very early ECMO plus standard pharmacotherapy
Number of subjects: 428

Group type: COMPARATOR
Intervention: Standard pharmacotherapy alone
Number of subjects: 428
Study: 35589611

Group type: EXPERIMENTAL
Intervention: Biocon's Insulin‐70/30
Number of subjects: 78

Group type: COMPARATOR
Intervention: HUMULIN‐70/30
Number of subjects: 78
Study: 34628377

Group type: EXPERIMENTAL
Intervention: Lamellar immediate-prostheses under the control of diagnostic staining of the mucous membrane
Number of subjects: 2

Group type: COMPARATOR
Intervention: Traditional method of prosthesis manufacture
Number of subjects: 2
Study: 36000541

Group type: EXPERIMENTAL
Intervention: Zanidatamab plus chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Zanidatamab plus chemotherapy + tislelizumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Trastuzumab plus chemotherapy (standard of care)
Number of subjects: 0
Study: 32536177

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 600 mg every 12 hours for 10 days
Number of subjects: 179

Group type: COMPARATOR
Intervention: Control group (no NAC)
Number of subjects: 179
Study: 35175092

Group type: EXPERIMENTAL
Intervention: PTSD Coach Online (culturally adapted web-based intervention)
Number of subjects: 87
Study: 33863241

Group type: EXPERIMENTAL
Intervention: Low-intensity parent advocacy program (three sessions)
Number of subjects: 0
Study: 33222860

Group type: EXPERIMENTAL
Intervention: Antibiotic therapy (tulathromycin, 2.5 mg/kg subcutaneous)
Number of subjects: 357

Group type: COMPARATOR
Intervention: Placebo (sterile saline, equal volume subcutaneous)
Number of subjects: 357
Study: 35993223

Group type: EXPERIMENTAL
Intervention: Adductor canal block (ACB) with 15 mL mixture of ropivacaine 0.2% with isotonic saline and steroids on post-operative day 14 (POD-14)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Daily consumption of analgesic (control group)
Number of subjects: 70
Study: 36250527

Group type: EXPERIMENTAL
Intervention: Time-restricted eating (TRE) group (n=11)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (unrestricted feeding; n=8)
Number of subjects: 19
Study: 35195052

Group type: EXPERIMENTAL
Intervention: B-vitamin supplementation
Number of subjects: 707

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 707
Study: 34260816

Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 1155

Group type: COMPARATOR
Intervention: Dalteparin
Number of subjects: 1155
Study: 34810130

Group type: EXPERIMENTAL
Intervention: Concurrent chemotherapy-immunotherapy with pembrolizumab and multisite radiotherapy
Number of subjects: 460

Group type: COMPARATOR
Intervention: Concurrent chemotherapy-immunotherapy with pembrolizumab
Number of subjects: 460
Study: 36208670

Group type: COMPARATOR
Intervention: Control (2% dimethyl sulfoxide, 2% Ringer, 96% propylene glycol)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 10 mM Ascorbate (non-specific ROS inhibitor)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 10 mM L-NAME (non-specific NOS inhibitor)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Ascorbate+L-NAME
Number of subjects: 32
Study: 34186271

Group type: EXPERIMENTAL
Intervention: Metacognitive training (MCT)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Psychoeducation
Number of subjects: 122
Study: 32460793

Group type: EXPERIMENTAL
Intervention: T-Beer group (alcohol beer, 5.4%; n=13)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: T-Ethanol group (sparkling water with vodka, 5.4%; n=14)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: T-Water group (sparkling water, 0.0%; n=16)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: T-0.0Beer group (alcohol-free beer, 0.0%; n=15)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control Non-Training group (n=15)
Number of subjects: 73
Study: 33279444

Group type: EXPERIMENTAL
Intervention: Bidirectional continuous barbed suture (Quill™)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Discontinuous polyglactin 910 suture (Vicryl™)
Number of subjects: 82
Study: 32406783

Group type: EXPERIMENTAL
Intervention: Robotic Camera Steering Device (RCSD) controlled by head movements
Number of subjects: 45

Group type: COMPARATOR
Intervention: Human camera assistant
Number of subjects: 45
Study: 35224588

Group type: EXPERIMENTAL
Intervention: Ice packs (0 °C)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo cold packs (10 °C)
Number of subjects: 90
Study: 33143009

Group type: EXPERIMENTAL
Intervention: Peer-led physical activity intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Peer supporters
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Peer-led interventions
Number of subjects: 0
Study: 35318946

Group type: EXPERIMENTAL
Intervention: Physical training program (2-month duration)
Number of subjects: 147
Study: 36182207

Group type: EXPERIMENTAL
Intervention: 5% sodium hypochlorite deproteinization
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Transbond XT adhesive
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Orthocem adhesive
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no deproteinization)
Number of subjects: 40
Study: 34674645

Group type: EXPERIMENTAL
Intervention: Weekly multidisciplinary team‐led deprescribing rounds (using five steps of deprescribing)
Number of subjects: 260

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 260
Study: 32393353

Group type: EXPERIMENTAL
Intervention: Unilateral Salter pelvic osteotomy
Number of subjects: 15

Group type: COMPARATOR
Intervention: Bilateral Salter pelvic osteotomy
Number of subjects: 15
Study: 35083495

Group type: EXPERIMENTAL
Intervention: Local hyperthermia
Number of subjects: 1027

Group type: COMPARATOR
Intervention: Cryotherapy
Number of subjects: 1027
Study: 33907393

Group type: EXPERIMENTAL
Intervention: Nebulized glycopyrrolate (GLY)
Number of subjects: 1293

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1293
Study: 33337492

Group type: EXPERIMENTAL
Intervention: Volar locking plate internal fixation
Number of subjects: 146

Group type: COMPARATOR
Intervention: External fixation
Number of subjects: 146

Group type: COMPARATOR
Intervention: Percutaneous pinning
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Delay in surgery (1 week)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Preoperative pain (10-point increase)
Number of subjects: 146
Study: 33576003

Group type: EXPERIMENTAL
Intervention: Contrast-Enhanced Ultrasound (CEUS)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Standard Ultrasound
Number of subjects: 214

Group type: COMPARATOR
Intervention: Computed Tomography (CT)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Magnetic Resonance Imaging (MRI)
Number of subjects: 214
Study: 33567953

Group type: EXPERIMENTAL
Intervention: Kinesiology taping (KT) in addition to a 6-week exercise program
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group received a 6-week exercise program alone
Number of subjects: 80
Study: 33723919

Group type: EXPERIMENTAL
Intervention: CBD 0.5 mg/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CBD 1 mg/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CBD 2 mg/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CBD (all doses)
Number of subjects: 0
Study: 32762279

Group type: EXPERIMENTAL
Intervention: Male Veterans
Number of subjects: 599

Group type: COMPARATOR
Intervention: Male civilians
Number of subjects: 599
Study: 35351371

Group type: EXPERIMENTAL
Intervention: Ramucirumab alone (arm A)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Ramucirumab plus Paclitaxel (arm B)
Number of subjects: 112
Study: 34312821

Group type: EXPERIMENTAL
Intervention: Stellate ganglion blockade (SGB) with variable combinations of bupivacaine, lidocaine, ropivacaine, and dexamethasone
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Stellate ganglion blockade (SGB)
Number of subjects: 13
Study: 34939343

Group type: EXPERIMENTAL
Intervention: 3D-printed bolus
Number of subjects: 75

Group type: COMPARATOR
Intervention: Conventional bolus
Number of subjects: 75
Study: 32024435

Group type: EXPERIMENTAL
Intervention: Cotrimoxazole prophylaxis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (stopping cotrimoxazole)
Number of subjects: 0
Study: 35057434

Group type: EXPERIMENTAL
Intervention: 6 g/d salt (NaCl)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 32505790

Group type: EXPERIMENTAL
Intervention: Outpatient endometrial sampling (OES)
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Hysteroscopic resectoscope-directed biopsies (HYbiopsy)
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Combination of OES and HYbiopsy
Number of subjects: 266

Group type: COMPARATOR
Intervention: OES alone
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: HYbiopsy
Number of subjects: 266
Study: 36357586

Group type: EXPERIMENTAL
Intervention: Treadmill training with virtual reality (TT + VR)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Treadmill training alone (TT)
Number of subjects: 124
Study: 33331835

Group type: EXPERIMENTAL
Intervention: Blueberry supplementation (24 g d-1 for 90 days)
Number of subjects: 38
Study: 32464260

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 32870478

Group type: EXPERIMENTAL
Intervention: CMAA and Montelukast
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: CMAA
Number of subjects: 180

Group type: COMPARATOR
Intervention: Montelukast
Number of subjects: 180
Study: 36513296

Group type: EXPERIMENTAL
Intervention: Stress + uncertain safety condition
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Less restrained individuals
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: More restrained individuals
Number of subjects: 147

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 147
Study: 33451086

Group type: EXPERIMENTAL
Intervention: SIT (Sprint Interval Training)
Number of subjects: 32
Study: 32236726

Group type: EXPERIMENTAL
Intervention: Molar incisor hypomineralization (MIH)
Number of subjects: 731

Group type: EXPERIMENTAL
Intervention: GT/GG genotype in rs739837 polymorphism
Number of subjects: 731
Study: 34397206

Group type: EXPERIMENTAL
Intervention: HP/TAZ (halobetasol propionate 0.01% and tazarotene 0.045%)
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: HP/TAZ
Number of subjects: 232

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 232
Study: 32333875

Group type: EXPERIMENTAL
Intervention: Oral semaglutide 3 mg
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Oral semaglutide 7 mg
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Oral semaglutide 14 mg
Number of subjects: 243

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Liraglutide 0.9 mg
Number of subjects: 243
Study: 35927708

Group type: EXPERIMENTAL
Intervention: Telehealth HIIT exercise (16 weeks, 2 days per week)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No-exercise control group
Number of subjects: 0
Study: 34582992

Group type: EXPERIMENTAL
Intervention: Electrosurgical transection using a monopolar electrosurgical device (Bovie)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sharp transection using a No. 10 scalpel blade
Number of subjects: 12
Study: 33355949

Group type: EXPERIMENTAL
Intervention: Isavuconazole
Number of subjects: 62

Group type: COMPARATOR
Intervention: Voriconazole
Number of subjects: 62
Study: 32750431

Group type: EXPERIMENTAL
Intervention: Partner-assisted intervention (couples participate in half of the group sessions and telephone calls)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard weight management program (individual participation)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Partner-assisted intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard weight management program
Number of subjects: 0
Study: 33802738

Group type: EXPERIMENTAL
Intervention: Paleolithic diet with supervised exercise
Number of subjects: 0

Group type: COMPARATOR
Intervention: Paleolithic diet with general exercise recommendations
Number of subjects: 0
Study: 35836116

Group type: EXPERIMENTAL
Intervention: ESP block with 0.375% ropivacaine (0.4 mL/kg)
Number of subjects: 3

Group type: COMPARATOR
Intervention: SHAM block with 0.9% saline (0.4 mL/kg)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 3
Study: 34269067

Group type: EXPERIMENTAL
Intervention: Tislelizumab plus concurrent chemoradiotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo plus concurrent chemoradiotherapy
Number of subjects: 0
Study: 32889533

Group type: EXPERIMENTAL
Intervention: Micronutrient tablet intervention in Gambian cohort
Number of subjects: 991

Group type: EXPERIMENTAL
Intervention: Food-based micronutrient intervention in Indian cohort
Number of subjects: 991
Study: 35568330

Group type: EXPERIMENTAL
Intervention: Mepolizumab (300 mg subcutaneous every 4 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34260996

Group type: EXPERIMENTAL
Intervention: Papanicolaou cervical-cancer screening
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-gender specific tests (blood-pressure and blood-sugar checks)
Number of subjects: 0
Study: 33667113

Group type: EXPERIMENTAL
Intervention: Adhesive wound closure (AWC) device for 3 months
Number of subjects: 14

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Adhesive wound closure (AWC) device
Number of subjects: 14
Study: 32384291

Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg/kg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg/kg) + Magnesium sulfate (3g)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 32495573

Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine (TCM)
Number of subjects: 42
Study: 34148379

Group type: EXPERIMENTAL
Intervention: MCT+CR (n=163)
Number of subjects: 332

Group type: COMPARATOR
Intervention: Usual CR (n=169)
Number of subjects: 332
Study: 36084236

Group type: EXPERIMENTAL
Intervention: Levagen+ (600 mg twice daily for 4 weeks)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (twice daily for 4 weeks)
Number of subjects: 60
Study: 34042543

Group type: EXPERIMENTAL
Intervention: Negative Pressure Wound Therapy (NPWT)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Conventional Therapy (Control)
Number of subjects: 21
Study: 32492168

Group type: EXPERIMENTAL
Intervention: Pork intake
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Red meat intake
Number of subjects: 12

Group type: COMPARATOR
Intervention: Habitual red and processed meat intake
Number of subjects: 12
Study: 35273049

Group type: EXPERIMENTAL
Intervention: High-dose pyrazinamide (40 mg/kg) and rifampicin (35 mg/kg) along with standard doses of isoniazid and ethambutol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standardised TB treatment (6-month regimen)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-dose pyrazinamide-rifampicin regimen
Number of subjects: 0
Study: 33201227

Group type: EXPERIMENTAL
Intervention: 30 minutes of moderate-intensity aerobic exercise
Number of subjects: 0
Study: 32228143

Group type: EXPERIMENTAL
Intervention: Video consultations
Number of subjects: 0

Group type: COMPARATOR
Intervention: In-hospital consultations
Number of subjects: 0